Literature DB >> 33998043

In silico structure evaluation of BAG3 and elucidating its association with bacterial infections through protein-protein and host-pathogen interaction analysis.

Soumya Basu1, Aniket Naha1, Balaji Veeraraghavan2, Sudha Ramaiah1, Anand Anbarasu1.   

Abstract

BAG3, a co-chaperone protein with a Bcl-2-associated athanogene (BAG) domain, has diverse functionalities in protein-folding, apoptosis, inflammation, and cell cycle regulatory cross-talks. It has been well characterised in cardiac diseases, cancers, and viral pathogenesis. The multiple roles of BAG3 are attributed to its functional regions like BAG, Tryptophan-rich (WW), isoleucine-proline-valine-rich (IPV), and proline-rich (PXXP) domains. However, to study its structural impact on various functions, the experimental 3D structure of BAG3 protein was not available. Hence, the structure was predicted through in silico modelling and validated through computational tools and molecular dynamics simulation studies. To the best of our knowledge, the role of BAG3 in bacterial infections is not explicitly reported. We attempted to study them through an in-silico protein-protein interaction network and host-pathogen interaction analysis. From structure-function relationships, it was identified that the WW and PXXP domains were associated with cellular cytoskeleton rearrangement and adhesion-mediated response, which might be involved in BAG3-related intracellular bacterial proliferation. From functional enrichment analysis, Gene Ontology terms and topological matrices, 18 host proteins and 29 pathogen proteins were identified in the BAG3 interactome pertaining to Legionellosis, Tuberculosis, Salmonellosis, Shigellosis, and Pertussis through differential phosphorylation events associated with serine metabolism. Furthermore, it was evident that direct (MAPK8, MAPK14) and associated (MAPK1, HSPD1, NFKBIA, TLR2, RHOA) interactors of BAG3 could be considered as therapeutic markers to curb down intracellular bacterial propagation in humans.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  BAG3; bacterial infection; host-pathogen-interaction; molecular dynamics; protein-protein interaction

Mesh:

Substances:

Year:  2021        PMID: 33998043     DOI: 10.1002/jcb.29953

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  FN1 encoding fibronectin as a pivotal signaling gene for therapeutic intervention against pancreatic cancer.

Authors:  Gayathri Ashok; Sravan Kumar Miryala; Megha Treesa Saju; Anand Anbarasu; Sudha Ramaiah
Journal:  Mol Genet Genomics       Date:  2022-08-18       Impact factor: 2.980

Review 2.  A critical review of datasets and computational suites for improving cancer theranostics and biomarker discovery.

Authors:  Gayathri Ashok; Sudha Ramaiah
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

3.  Structural chemistry and molecular-level interactome reveals histidine kinase EvgS to subvert both antimicrobial resistance and virulence in Shigella flexneri 2a str. 301.

Authors:  Aniket Naha; Sudha Ramaiah
Journal:  3 Biotech       Date:  2022-09-03       Impact factor: 2.893

4.  Emergence of Meropenem Resistance Among Cefotaxime Non-susceptible Streptococcus pneumoniae: Evidence and Challenges.

Authors:  Rosemol Varghese; Soumya Basu; Ayyanraj Neeravi; Agilakumari Pragasam; V Aravind; Richa Gupta; Angel Miraclin; Sudha Ramaiah; Anand Anbarasu; Balaji Veeraraghavan
Journal:  Front Microbiol       Date:  2022-02-03       Impact factor: 5.640

5.  Datasets comprising the quality validations of simulated protein-ligand complexes and SYBYL docking scores of bioactive natural compounds as inhibitors of Mycobacterium tuberculosis protein-targets.

Authors:  Sravan Kumar Miryala; Soumya Basu; Aniket Naha; Reetika Debroy; Sudha Ramaiah; Anand Anbarasu; Saravanan Natarajan
Journal:  Data Brief       Date:  2022-04-10

6.  Network metrics, structural dynamics and density functional theory calculations identified a novel Ursodeoxycholic Acid derivative against therapeutic target Parkin for Parkinson's disease.

Authors:  Aniket Naha; Sanjukta Banerjee; Reetika Debroy; Soumya Basu; Gayathri Ashok; P Priyamvada; Hithesh Kumar; A R Preethi; Harpreet Singh; Anand Anbarasu; Sudha Ramaiah
Journal:  Comput Struct Biotechnol J       Date:  2022-08-10       Impact factor: 6.155

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.